These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15817135)

  • 1. Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
    Moran-Gates T; Zhang K; Baldessarini RJ; Tarazi FI
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):439-44. PubMed ID: 15817135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
    Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
    Liu YP; Huang TS; Tung CS; Lin CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():81-90. PubMed ID: 25151304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning.
    Zhang K; Tarazi FI; Davids E; Baldessarini RJ
    Neuropsychopharmacology; 2002 May; 26(5):625-33. PubMed ID: 11927187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice.
    Sifeddine W; Ba-M'hamed S; Landry M; Bennis M
    Pharmacol Rep; 2023 Apr; 75(2):342-357. PubMed ID: 36787018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit/hyperactivity disorder and reading disorder.
    de Jong CG; Van De Voorde S; Roeyers H; Raymaekers R; Allen AJ; Knijff S; Verhelst H; Temmink AH; Smit LM; Rodriques-Pereira R; Vandenberghe D; van Welsen I; ter Schuren L; Al-Hakim M; Amin A; Vlasveld L; Oosterlaan J; Sergeant JA
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):699-707. PubMed ID: 20035588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atomoxetine on levels of monoamines and related substances in discrete brain regions in mice intermittently deprived of rapid eye movement sleep.
    Niijima F; Saito H; Murai S; Arai Y; Nakagawasai O; Tan-No K; Watanabe H; Hiraga H; Tadano T
    Biol Pharm Bull; 2010; 33(4):617-21. PubMed ID: 20410595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.
    Harfterkamp M; Buitelaar JK; Minderaa RB; van de Loo-Neus G; van der Gaag RJ; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):194-9. PubMed ID: 23578015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents.
    Scott NG; Ripperger-Suhler J; Rajab MH; Kjar D
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):197-203. PubMed ID: 20578932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.
    Leuchter AF; McGough JJ; Korb AS; Hunter AM; Glaser PE; Deldar A; Durell TM; Cook IA
    J Psychiatr Res; 2014 Jul; 54():11-8. PubMed ID: 24726639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
    Shibasaki Y; Hayata-Takano A; Hazama K; Nakazawa T; Shintani N; Kasai A; Nagayasu K; Hashimoto R; Tanida M; Katayama T; Matsuzaki S; Yamada K; Taniike M; Onaka Y; Ago Y; Waschek JA; Köves K; Reglődi D; Tamas A; Matsuda T; Baba A; Hashimoto H
    Neuroscience; 2015 Jun; 297():95-104. PubMed ID: 25841321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.
    Somkuwar SS; Jordan CJ; Kantak KM; Dwoskin LP
    Neuropsychopharmacology; 2013 Dec; 38(13):2588-97. PubMed ID: 23822950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Lapshina OV; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):66-8. PubMed ID: 18646384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children].
    Zavadenko NN; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):43-7. PubMed ID: 18833117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.
    Troost PW; Steenhuis MP; Tuynman-Qua HG; Kalverdijk LJ; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):611-9. PubMed ID: 17069549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M; Núñez F; Ahern S; Cuffí ML; Carbonell L; Sánchez S; Fernández-Dueñas V; Ciruela F
    Neurosci Lett; 2011 Apr; 494(1):44-8. PubMed ID: 21362462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.